Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

FX006

Single 5 mL IA injection

DRUG

Placebo

Single 5 mL IA injection

DRUG

TCA IR 40

Single 1 mL IA injection

Trial Locations (38)

10323

Vilnius

16635

Duncansville

23606

Newport News

27518

Cary

28209

Charlotte

30463

Bucharest

32720

DeLand

33012

Hialeah

33409

West Palm Beach

33462

Atlantis

34232

Sarasota

37912

PMG Research of Knoxville, Knoxville

37938

PMG Research of Knoxville, Knoxville

66206

Prairie Village

75231

Dallas

80209

Denver

85023

Phoenix

85712

Tucson

87102

Albuquerque

91303

Canoga Park

91606

North Hollywood

92103

San Diego

92801

Anaheim

Unknown

PMG Research of Cary, Cary

Aalborg

Ballerup Municipality

Vejle

Tallinn

Hong Kong

02292

Broadmeadow

03220

Geelong

02291

Merewether

02065

St Leonards

04075

Sherwood

03145

Malvern

G1W4R4

Quebec

M9V4B4

Toronto

N8W1E6

Windsor

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT02357459 - Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter